101 related articles for article (PubMed ID: 1803369)
1. [Frequency and character of side effects of anti-tubercular drugs].
Kazakov KS; Kalankhodzhaev AA; Kozarez MI; Atamatov KhA; Mukhtarov DZ; Ikramova MI; Gamzaeva NF; Magrupov IaA
Probl Tuberk; 1991; (12):28-31. PubMed ID: 1803369
[TBL] [Abstract][Full Text] [Related]
2. [Adverse reactions of antituberculous agents, especially about its onset and duration].
Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K
Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
[TBL] [Abstract][Full Text] [Related]
3. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
4. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
Ubaĭdullaev AM; Tashpulatova FK; Kazakov KS
Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
Batian AN; Abramovskaia AK; Batian ON
Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
[TBL] [Abstract][Full Text] [Related]
6. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
Chukanov VI; Kaminskaia GO; Livchane E
Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
Mordyk AV; Briukhanova NS; Kazakov AV
Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
[TBL] [Abstract][Full Text] [Related]
8. [Influence of adverse reactions due to chemotherapy on life quality indices in patients with infiltrative pulmonary tuberculosis].
Mordyk AV; Antropova VV
Probl Tuberk Bolezn Legk; 2008; (9):44-6. PubMed ID: 19065734
[TBL] [Abstract][Full Text] [Related]
9. [Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy].
Onaka A
Kekkaku; 1987 Dec; 62(12):672-5. PubMed ID: 3448353
[No Abstract] [Full Text] [Related]
10. [Results of perthoracic liver biopsy in lung tuberculosis before and after tuberculostatic therapy].
Pickroth G; Henkel HG
Z Arztl Fortbild (Jena); 1966 Sep; 60(17):1007-18. PubMed ID: 5995285
[No Abstract] [Full Text] [Related]
11. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
Shmelev EI; Stepanian IE
Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
[TBL] [Abstract][Full Text] [Related]
12. [Protective effect of silibinin on liver injury induced by antituberculosis drugs].
Li J; Lin WF; Pan YY; Zhu XY
Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):385-6. PubMed ID: 20510009
[No Abstract] [Full Text] [Related]
13. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. [Amyloidosis lesions of the digestive organs in patients with tuberculosis and chronic nonspecific lung diseases].
Mazur PE
Probl Tuberk; 1989; (11):46-9. PubMed ID: 2616559
[TBL] [Abstract][Full Text] [Related]
16. [Acute pancreatitis in patients with pulmonary tuberculosis].
Sementsov IIa
Probl Tuberk; 2000; (2):33-5. PubMed ID: 10838907
[TBL] [Abstract][Full Text] [Related]
17. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
Al-Rubaish AM; Madania AA; Al-Muhanna FA
Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
[TBL] [Abstract][Full Text] [Related]
19. [New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment].
Mishin VIu; Shevchuk EIu; Tsygankov BD; Losev LV
Probl Tuberk Bolezn Legk; 2008; (6):6-10. PubMed ID: 18710046
[TBL] [Abstract][Full Text] [Related]
20. [Enzymatic parameters of the liver function in patients with active pulmonary tuberculosis and adverse reactions to chemotherapeutic drugs].
Bondarenko VP
Probl Tuberk; 1979 Nov; (11):37-40. PubMed ID: 530967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
